These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6086923

  • 1. Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: central dopamine receptor activity.
    Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson AM, Thorberg SO, Nilsson JL, Svensson K, Hjorth S.
    J Med Chem; 1984 Aug; 27(8):1030-6. PubMed ID: 6086923
    [Abstract] [Full Text] [Related]

  • 2. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
    Wikström H, Andersson B, Elebring T, Svensson K, Carlsson A, Largent B.
    J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.
    Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A.
    Psychopharmacology (Berl); 1983 Dec; 81(2):89-99. PubMed ID: 6415751
    [Abstract] [Full Text] [Related]

  • 5. The search for selective dopaminergic autoreceptor agonists.
    Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A, Nilsson JL.
    J Neural Transm Suppl; 1983 Dec; 18():131-7. PubMed ID: 6576112
    [Abstract] [Full Text] [Related]

  • 6. Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics.
    Rollema H, Mastebroek D, Wikström H, Svensson K, Carlsson A, Sundell S.
    J Med Chem; 1986 Oct; 29(10):1889-95. PubMed ID: 3761308
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Indolizidine and quinolizidine derivatives of the dopamine autoreceptor agonist 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP).
    Bøgesø KP, Arnt J, Lundmark M, Sundell S.
    J Med Chem; 1987 Jan; 30(1):142-50. PubMed ID: 3806591
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. trans-N-n-Propyl-7-hydroxy-octahydrobenzo(f)quinoline, a rigid 3-PPP analogue with greater potency but lack of selectivity for dopamine autoreceptors.
    Van Oene JC, Houwing HA, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1983 Mar 04; 87(4):491-5. PubMed ID: 6406238
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D, Hjorth S, Carlsson A.
    Eur J Pharmacol; 1984 Oct 30; 106(1):185-9. PubMed ID: 6099268
    [Abstract] [Full Text] [Related]

  • 18. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr 30; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 19. Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.
    Mulder AH, Draper R, Sminia P, Schoffelmeer AN, Stoof JC.
    Eur J Pharmacol; 1985 Jan 08; 107(3):291-7. PubMed ID: 3979429
    [Abstract] [Full Text] [Related]

  • 20. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
    Jackson D, Carlsson A, Hjorth S, Lindberg P.
    J Neural Transm; 1982 Jan 08; 53(4):233-45. PubMed ID: 6286867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.